Interaction of implantable defibrillator therapy with angiotensin- converting enzyme deletion/insertion polymorphism

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 10, 2004, Pages 1162-1166

  Bedi, Maninder S ^a   Postava, Lisa A ^a   Murali, Srinivas ^a   Macgowan, Guy A ^a   Mathier, Michael ^a   McNamara, Dennis M ^a   London, Barry ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Arrhythmias; Gene polymorphisms; Heart failure; Implantable cardioverter defibrillator

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ARTICLE; DEFIBRILLATOR; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC RISK; GENOTYPE; HEART ASSIST DEVICE; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL RATE;

ALLELES; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SURVIVAL RATE; TELEMETRY;

EID: 7044235410     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03609.x     Document Type: Article

References (17)

1. Torre Amione G: The syndrome of heart failure: Emerging concepts in the understanding of its pathogenesis and treatment. Curr Opin Cardiology 1999;14:193.
2. Niu T, Chen X, Xu X: Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular diseases. Drugs 2002;62:977-993.
3. Andersson B, Sylven C: The DD genotype of the angiotensin converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996;28:162-167.
4. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Ferryman MB: Angiotensin converting enzyme DD genotype in patients with ischemic or dilated cardiomyopathy. Lancet 1993;342:1073-1075.
5. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
6. McNamara DM, Holubkov R, Janosko K, Palmer A, Wang JJ, MacGowan GA, Murali S, Rosenblum WD, London B, Feldman AM: Pharmacogenetic interactions between beta blocker therapy and angiotensin converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation 2001;103:1644-1648.
7. Fuentes RM, Perola M, Nissinen A, Tuomilehto J: ACE gene and physical activity, blood pressure and hypertension: A population study in Finland. J Appl Physiol 2002;92:2508-2512.
8. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PWF, Vasan RS, Myers RH, Levy D: Absence of association or genetic linkage between the angiotensin converting enzyme gene and left ventricular mass. N Engl J Med 1996:334:1023-1028.
9. Jorgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamaki K, Kastrup J, Havndrup O, Bundgaard H, Kyst MJ, Christiansen M, Andersen PS, Reiber JH: Predictors of coronary in-stent restenosis: Importance of angiotensin converting enzyme gene polymorphism and treatment with angiotensin converting enzyme inhibitors. J Am Coll Cardiol 2001;38:1434-1439.
10. Uretsky BF, Pina I, Quigg RJ, Brill JV, MacInerey EJ, Mintzer R, Armstrong PW: Beyond drug therapy: Nonpharmacologic care of the patient with advanced heart failure. Am Heart J 1998;135:S264-S284.
11. Santini M, Ricci R, Pignalberi C, Ansalone G: Electrotherapeutic management of patients with heart failure. Am J Cardiovasc Drugs 2001;4:227-231.
12. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews MS, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Moonseong H, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
14. AVID, The Antiarrhythmics versus Implantable Defibrillators Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
15. Keating MT, Sanguinetti MC: Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001;104:569-580.
16. Bigger JT: Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002;346:931-933.
17. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT: Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002;297:1333-1336